EGFR Inhibitors
| Cat. No. | Product Name / Activity |
|---|---|
| 5318 | AEE 788 |
| Potent EGFR and VEGFR inhibitor | |
| 6812 | Afatinib dimaleate |
| Potent dual specificity EGFR/HER2 inhibitor; active in vivo | |
| 1276 | AG 1478 hydrochloride |
| Highly potent EGFR-kinase inhibitor | |
| 0414 | AG 490 |
| EGFR-kinase inhibitor. Also JAK2, JAK3 inhibitor | |
| 1555 | AG 825 |
| Selective ErbB2 inhibitor | |
| 5022 | BMS 599626 dihydrochloride |
| Potent, selective EGFR and ErbB2 inhibitor | |
| 5916 | Canertinib dihydrochloride |
| Potent EGFR kinase inhibitor | |
| 6231 | Dacomitinib |
| Potent irreversible pan ErbB inhibitor | |
| 7424 | EMI 48 |
| Inhibitor of EGFR mutants | |
| 7194 | Erlotinib Hydrochloride |
| Potent, reversible EGFR tyrosine kinase inhibitor | |
| 1110 | Genistein |
| EGFR kinase inhibitor. Also estrogen and PPARγ ligand | |
| 2239 | GW 583340 dihydrochloride |
| Potent dual EGFR/ErbB2 inhibitor; orally active | |
| 3580 | HKI 357 |
| Dual irreversible inhibitor of ErbB2 and EGFR | |
| 6813 | Ibrutinib |
| Potent ErbB4 inhibitor; also inhibits BTK | |
| 3000 | Iressa |
| Orally active, selective EGFR inhibitor | |
| 6962 | JBJ-03-142-02 |
| Highly potent EGFR and ErbB2 inhibitor; inhibts wild type and mutated receptors | |
| 3352 | JNJ 28871063 hydrochloride |
| Potent ErbB receptor family inhibitor | |
| 6811 | Lapatinib |
| Potent and selective dual ErbB2 (HER-2) and EGFR inhibitor | |
| 7371 | Neratinib |
| Potent HER2 receptor tyrosine kinase and EGFR kinase inhibitor | |
| 2615 | PD 158780 |
| Potent ErbB receptor family inhibitor | |
| 6349 | Pelitinib |
| Potent and irreversible EGFR inhibitor; orally bioavailable | |
| 4941 | PKI 166 hydrochloride |
| Potent EGFR-kinase inhibitor | |
| 2794 | PP 3 |
| EGFR-kinase inhibitor. Also Src kinase negative control | |
| 3599 | TAK 165 |
| Potent and selective ErbB2 inhibitor | |
| 7640 | Tucatinib |
| Potent and selective ErbB2 inhibitor | |
| 3115 | WHI-P 154 |
| Potent EGFR inhibitor. Also inhibits JAK3 | |
| 6290 | WZ 4002 |
| Potent mutant-selective EGFR inhibitor |
Cancer Research Product Guide
Our Cancer Research Guide highlights over 750 products for cancer research.
Request copyRequest PDFKinases Product Listing
Our Kinase listing highlights over 400 products for kinase research.
Request copyRequest PDFAngiogenesis in Cancer Life Science Poster
Taken from the Cancer Product Guide Edition 3
Our Angiogenesis in Cancer poster summarizes the pathogenesis of angiogenesis in cancer, as well as some of the main angiogenesis therapeutic targets.
Request copyDownload PDFSchizophrenia Life Science Poster
Written by Justin M. Saunders and Javier González-Maeso
Our Schizophrenia poster highlights the targets and pathways representing the most promising strategies to pursue for novel drug development.
Request copyDownload PDF